Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
GHK-Cu vs NAD+ head-to-head comparison
DSIP is not FDA-approved for any indication and is not approved in the EU, UK, or other major regulated markets
GHK-Cu Dosing in Hepatic Impairment: What Clinicians Need to Know At a glance GHK-Cu / a naturally occurring tripeptide bound to copper(II), available through 503A compounding pharmacies FDA status / not FDA-approved
The honest statement is that the relationship between DSIP dose and effect in humans is unmapped , and the studied doses are simply the only numbers with any published basis at all
Chronic low-grade inflammation, often called "inflammaging," is now recognized as a central driver of biological aging, contributing to cardiovascular disease, neurodegeneration, insulin resistance, and loss of muscle mass
US$ 22.13
US$ 28.87
US$ 29.92
